12/12/2017 We successfully presented our poster, entitled "ADAR1-Mediated GLI1 Editing Promotes Malignant Self-Renewal in Multiple Myeloma" at ASH (American Society of Hematology) 2017 in Atlanta, GA! There were many excellent presentations and it's so exciting to hear about more new myeloma therapies on the horizon.
12/4/2017 The Crews Lab is excited to announce the publication of a key new paper in multiple myeloma, out in Nature Communications. The team has worked diligently to develop new patient-derived models for multiple myeloma research and to identify molecular mechanisms of disease progression and drug resistance. See the UCSD press release here.
12/1/2017 The Crews Lab will be working with Dr. Catriona Jamieson's lab along with biochemist Dr. Michael Burkart, also at UCSD, on a project that was just selected to receive $2.7M in funding from CIRM to test a new potential therapy for AML. Congrats to the Jamieson and Burkart teams!
11/4/2017 The Crews Lab partnered with the San Diego Multiple Myeloma Patient Support Group to participate in the Leukemia and Lymphoma Society's Annual Light the Night event to show support for research on blood cancer to save lives.
Video Feature - Dr. Crews was featured on the homepage of The Science Network, speaking at the Annual Division of Regenerative Medicine symposium earlier this year about her work in multiple myeloma.
***Student Research Opportunities Available Contact the Crews Lab for more information.***
10/9/2017 We were delighted to host the Annual Multiple Myeloma Patient Support Group Symposium at the Moores Cancer Center! Thank you to all who participated and attended, especially speakers Dr. Aaron Goodman and Christine Zoumas.
9/21/2017 Dr. Crews presented some of the lab's recent work at the Moores Cancer Center Fellows Networking meeting, 4pm @ Comer Commons
9/8/2017 Attended the 29th Annual Usha Mahajani Symposium on Molecular Medicine - many fantastic presentations on cancer heterogeneity and therapy resistance!
8/18/2017 Attended the Annual International Myeloma Foundation Patient and Family Seminar. So inspired and motivated after hearing the needs and challenges that multiple myeloma patients face today. I'm taking new ideas back to the lab with a mission to cure!